Ibandronate: The loading dose concept in the treatment of metastatic bone pain
Background/Aim: Severe bone pain is experienced by 60–80% of patients with metastatic bone disease, and has a profound impact on quality of life. Therefore, effective pain relief is an important goal in managing metastatic bone disease. Orthopedic surgeons are often challenged with patients presenti...
Main Authors: | Gerrit Steffen Maier, Christian Eberhardt, Andreas Alois Kurth |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Journal of Bone Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137415300348 |
Similar Items
-
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
by: Richard Derman, et al.
Published: (2009-09-01) -
Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study
by: Nurten Eskiyurt, et al.
Published: (2012-04-01) -
VIBE: Evaluation of Ibandronate Efficacy - Original Investigation
by: J-Y Reginster, et al.
Published: (2008-12-01) -
Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: A radiographic assessment
by: V Venkataramana, et al.
Published: (2014-01-01) -
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01)